Hipogonadismo de inicio tardío en el hombre

Resumen El hipogonadismo de inicio tardio en el hombre puede ser definido como un sindrome clinico y de laboratorio asociado al envejecimiento del individuo, caracterizado por la presencia concomitante de sintomas y una disminucion de los niveles sericos de testosterona (bajo los niveles sericos normales del adulto joven sano). La deficiencia de androgenos se expresa por sintomatologia variada y poco especifica, destacando las manifestaciones de la estera sexual. En estos pacientes se debe solicitar los niveles sericos de testosterona total. No se recomienda el tamizaje de hipogonadismo en poblacion general. Los riesgos y beneficios de la terapia con testosterona deben ser discutidos con el paciente. La ausencia de respuesta sintomatica en 3-6 meses debe hacer suspender la suplementacion y buscar otras patologias que expliquen el cuadro clinico. El adecuado diagnostico y tratamiento de estos pacientes se traduce en una significativa mejoria de la calidad de vida, de la funcion sexual y sus parametros metabolicos.

• Publication year

  2014

• Venue

  Revista Médica Clínica Las Condes

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/S0716-8640(14)70012-4
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular mechanisms of androgen action--a historical perspective.

  2011cited by this paper
• Testosterone deficiency in testicular germ-cell cancer patients is not influenced by oncological treatment.

  2011cited by this paper
• Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline.

  2010cited by this paper
• Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations.

  2009cited by this paper
• Investigation, treatment and monitoring of late-onset hypogonadism in males.

  2009cited by this paper
• Free testosterone measurement by the analog displacement direct assay: old concerns and new evidence.

  2008cited by this paper
• Androgen deficiency, diabetes, and the metabolic syndrome in men

  2007cited by this paper
• Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline.

  2006cited by this paper
• Tietz Textbook of Clinical Chemistry and Molecular Diagnostics

  2005cited by this paper
• Andropause for thought.

  2003cited by this paper
• Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging.

  2001cited by this paper
• Attenuation of luteinizing hormone secretory burst amplitude as a proximate basis for the hypoandrogenism of healthy aging in men.

  1992cited by this paper
• Reproductive functions in young fathers and grandfathers.

  1982cited by this paper
• Letter: Reallocation of resources.

  1976cited by this paper
• NOTE ON THE EFFECTS PRODUCED ON MAN BY SUBCUTANEOUS INJECTIONS OF A LIQUID OBTAINED FROM THE TESTICLES OF ANIMALS.

  1889cited by this paper

• No citing papers are available for this paper.